SCHEMBL14435692

SCHEMBL14435692

CCC(C(=O)c1ccc(CO)cc1)C(=O)c1ccc(OC)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.50
GSK3B P49841 1/20 0.47
TDP1 Q9NUW8 2/20 0.47
ALDH1A1 P00352 2/20 0.46
CYP1A2 P05177 1/20 0.46
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
NPC1 O15118 1/20 0.45
POLB P06746 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
LMNA P02545 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
SLC6A3 Q01959 1/20 0.45
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
KMT2A Q03164 2/20 0.44
PPARG P37231 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5217775 0.90 GSK3B (0.56) LDHAGSK3BALDH1A1CYP1A2CES2
SCHEMBL2290396 0.83 ALDH1A1 (0.60) LDHAGSK3BALDH1A1CYP1A2CES2
SCHEMBL7100665 0.80 ALDH1A1 (0.63) GSK3BTDP1ALDH1A1CYP1A2NPC1
SCHEMBL16171211 0.80 ALDH1A1 (0.51) LDHATDP1ALDH1A1CYP1A2CES2
SCHEMBL12489656 0.80 ALDH1A1 (0.48) LDHAGSK3BTDP1ALDH1A1CYP1A2
SCHEMBL5940583 0.80 RAB9A (0.61) GSK3BALDH1A1CES2CES1NPC1
SCHEMBL14275249 0.80 CES2 (0.73) LDHAGSK3BALDH1A1CES2CES1
SCHEMBL23295612 0.79 HDAC3 (0.50) GSK3BTDP1ALDH1A1CYP1A2CES2
Alcohol SCHEMBL2947640 0.77 IDO1 (0.54) LDHAALDH1A1SMN1; SMN2SLC6A4CA1
SCHEMBL27329 0.77 IDO1 (0.58) LDHAALDH1A1SMN1; SMN2SLC6A4CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007098090-A2 TREATMENT OF HYPERPROLIFERATIVE DISEASES WITH N-OXIDES OF ESTROGEN RECEPTOR MODULATORS NOVACEA, INC. (US) 2007-08-30 WO disclosed